NasdaqGM - Nasdaq Real Time Price USD
Ocular Therapeutix, Inc. (OCUL)
7.11
-0.06
(-0.84%)
As of 10:40:33 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 3 |
| Avg. Estimate | -0.35 | -0.35 | -1.39 | -1.22 |
| Low Estimate | -0.37 | -0.38 | -1.49 | -1.27 |
| High Estimate | -0.3 | -0.31 | -1.23 | -1.18 |
| Year Ago EPS | -0.26 | -0.22 | -1.05 | -1.39 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 10 | 11 |
| Avg. Estimate | 13.1M | 13.95M | 53.97M | 70.15M |
| Low Estimate | 12M | 12.56M | 49.88M | 52.3M |
| High Estimate | 14.8M | 15.1M | 58M | 100M |
| Year Ago Sales | 16.44M | 15.43M | 63.72M | 53.97M |
| Sales Growth (year/est) | -20.30% | -9.53% | -15.31% | 29.99% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.21 | -0.21 | -0.22 | -0.28 |
| EPS Actual | -0.26 | -0.22 | -0.29 | -0.37 |
| Difference | -0.05 | -0.01 | -0.07 | -0.09 |
| Surprise % | -21.88% | -6.45% | -31.82% | -33.00% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.35 | -0.35 | -1.39 | -1.22 |
| 7 Days Ago | -0.29 | -0.3 | -1.21 | -1.18 |
| 30 Days Ago | -0.29 | -0.3 | -1.21 | -1.18 |
| 60 Days Ago | -0.29 | -0.3 | -1.21 | -1.18 |
| 90 Days Ago | -0.25 | -0.26 | -1.02 | -1.07 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | 3 | 3 | 3 | 2 |
| Down Last 30 Days | 3 | 3 | 3 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| OCUL | -33.33% | -60.60% | -32.88% | 12.23% |
| S&P 500 | 13.17% | 2.85% | 7.92% | 13.78% |
Upgrades & Downgrades
| Maintains | Needham: Buy to Buy | 5/6/2025 |
| Initiated | William Blair: Outperform | 4/8/2025 |
| Reiterates | Needham: Buy to Buy | 4/8/2025 |
| Initiated | RBC Capital: Outperform | 3/18/2025 |
| Initiated | Needham: Buy | 3/11/2025 |
| Maintains | Citizens Capital Markets: Market Outperform to Market Outperform | 3/4/2025 |
Related Tickers
EYPT EyePoint Pharmaceuticals, Inc.
5.76
+0.70%
VRDN Viridian Therapeutics, Inc.
12.64
+0.16%
INZY Inozyme Pharma, Inc.
3.9488
+178.08%
ETNB 89bio, Inc.
7.63
-0.20%
FDMT 4D Molecular Therapeutics, Inc.
3.2200
+0.62%
DAWN Day One Biopharmaceuticals, Inc.
6.23
+1.14%
CYTK Cytokinetics, Incorporated
30.48
+2.14%
NAMS NewAmsterdam Pharma Company N.V.
18.89
+1.02%
ABEO Abeona Therapeutics Inc.
5.73
-1.04%
MREO Mereo BioPharma Group plc
2.2100
+1.38%